Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1055 of 6351
-
New drug cocktail shows promise for tough blood cancers
Disease control CompletedThis phase II trial studies the side effects and how well liposome-encapsulated daunorubicin-cytarabine and gemtuzumab ozogamicin work in treating patients with acute myeloid leukemia that has come back (relapsed) or that does not respond to treatment (refractory) or high risk my…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a Chemo-Immunotherapy duo outsmart tough lung cancer?
Disease control Stopped earlyThis phase II pilot trial studies how well gemcitabine and nivolumab work in treating participants with small cell lung cancer that has spread to other parts of the body after other treatments have failed. Drugs used in chemotherapy, such as gemcitabine, work in different ways to…
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a smart pump prevent dangerous drops in blood pressure during C-Sections?
Disease control OngoingMaternal hypotension during spinal anaesthesia for Caesarean delivery may bring various adverse effects. It is therefore important to closely monitor hypotension during spinal anaesthesia, however current technology does not allow the blood pressure monitoring to respond in timel…
Sponsor: KK Women's and Children's Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Epilepsy drug may protect organs during heart surgery — trial tests the idea
Prevention Stopped earlyThe Val-CARD trial aims to answer the question: "Does the drug sodium valproate reduce complications affecting the heart and kidneys in patients having heart operations?" Sodium valproate is a drug commonly used in the treatment of epilepsy. Recently it has been shown to protect …
Phase 1/2 • Sponsor: University of Leicester • Aim: Prevention
Last updated Aug 19, 2026 00:00 UTC
-
Could a lung cancer drug designed for one mutation work for another?
Disease control Stopped earlyA research study to evaluate the activity of alectinib for the Treatment of pretreated patients with advanced NSCLC that have confirmed RETrearrangement.
Phase 2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Heart artery blockage study: stent or meds – which is better?
Disease control Recruiting nowStudy design Prospective randomized open labeled multicenter study Hypotheses 1. In asymptomatic patients with ≥ 10% of myocardial ischemia: PCI (Percutaneous Coronary Intervention) with latest generation of drug eluting stents is superior to optimal medical therapy in terms o…
Sponsor: Aarhus University Hospital Skejby • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Immunotherapy combo shows promise in bladder cancer battle
Disease control OngoingThe purpose of this study is to compare nivolumab plus neoadjuvant gemcitabine/cisplatin (GC) chemotherapy, followed by post-surgery continuation of immuno-oncology (IO) therapy, with neoadjuvant GC chemotherapy alone in adult participants with previously untreated muscle-invasiv…
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug combo shows promise in tough brain cancer trial
Disease control OngoingThis phase II trial studies how well veliparib, radiation therapy, and temozolomide work in treating patients with newly diagnosed malignant glioma without H3 K27M or BRAFV600 mutations. Poly adenosine diphosphate (ADP) ribose polymerases (PARPs) are proteins that help repair DNA…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can a PET tracer reveal hidden brain inflammation?
Diagnosis Recruiting nowTo evaluate the potential usefulness of 18F-DPA714/FDPA positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various TSPO-related disease patients.
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
New antibody shows promise for Hard-to-Treat GVHD
Disease control CompletedThis is a Phase 1/2, Open-label, Dose Escalation study to investigate axatilimab in participants with active chronic graft versus host disease (cGVHD).
Phase 1/2 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Jun 26, 2026 17:19 UTC
-
Smart robotic sleeve reads muscle signals to restore arm movement after stroke
Disease control Recruiting nowA new clothing robotic arm was developed for multi-joint coordinated upper limb rehabilitation after stroke. Patients after stroke will be recruited to evaluate the rehabilitation effectiveness of the device assisted upper limb rehabilitation. Both patients with chronic stroke an…
Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Experimental antibody combo aims to boost immune attack on head and neck tumors
Disease control OngoingThis phase I trial studies how well anti-semaphorin 4D (SEMA4D) monoclonal antibody VX15/2503 (VX15/2503) with or without ipilimumab and/or nivolumab work in treating patients with stage I-IVA head and neck squamous cell cancer. Monoclonal antibodies, such as VX15/2503, ipilimuma…
Phase 1 • Sponsor: Emory University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New Triple-Drug cocktail aims to beat back tough leukemia
Disease control Recruiting nowThis phase I/II trial studies how well quizartinib, decitabine, and venetoclax work in treating participants with acute myeloid leukemia or high risk myelodysplastic syndrome that is untreated or has come back (relapsed). Quizartinib may stop the growth of cancer cells by blockin…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New hope for heart valve patients: less invasive procedure tested
Disease control OngoingThe objective of the trial is to evaluate the procedural safety and efficacy of the Medtronic TAVR system in patients with bicuspid aortic anatomy and severe aortic stenosis at low risk for SAVR
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a single injection rebuild knees? phase 3 trial underway
Disease control OngoingA randomized, double-blind, placebo-controlled, multi-center, phase 3 study to determine the safety and efficacy of TG-C in subjects with Kellgren and Lawrence Grade 2 or 3 Osteoarthritis of the Knee, Osteoarthritis Research Society International (OARSI) medial joint space narrow…
Phase 3 • Sponsor: Kolon TissueGene, Inc. • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Sound waves guided by MRI aim to zap prostate tumors with fewer side effects
Disease control OngoingMagnetic resonance imaging (MRI) has improved detection of clinically significant prostate cancer (PCa). MRI-guided transurethral ultrasound ablation (MRI-TULSA) system incorporates precise diagnosis and simultaneous ablation of prostate tissue enabling lesion-targeted treatment …
Sponsor: Turku University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug cocktail aims to beat back tough leukemia
Disease control Recruiting nowThis phase II trial studies how well liposome-encapsulated daunorubicin-cytarabine and venetoclax work in treating participants with acute myeloid leukemia that has come back (relapsed), does not respond to treatment (refractory), or has not been treated (untreated). Drugs used i…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for kids with severe colitis: drug trial shows promise
Disease control OngoingThe purpose of this study is to evaluate efficacy of golimumab in inducing clinical remission as assessed by the Mayo score, in pediatric participants with moderately to severely active ulcerative colitis (UC). In addition, the safety profile of golimumab, in pediatric participan…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Engineered immune cells take aim at tough lymphomas in first human test
Disease control OngoingThe body has different ways of fighting infection and disease. No single way is perfect for fighting cancer. This research study combines two different ways of fighting disease: antibodies and T cells. Antibodies are proteins that protect the body from disease caused by bacteria …
Phase 1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Immunotherapy combo shows promise in preventing esophageal cancer return
Disease control CompletedIn this study, participants with histologically diagnosed locally advanced esophageal squamous cell carcinoma who have received preoperative cisplatin-based chemoradiotherapy followed by surgery harbouring high risk of tumor recurrence will receive adjuvant cisplatin-based chemor…
Phase 2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC